Independent expert building machine-checkable, verifier-side primitives — validation that fails visibly instead of passing silently.
Why follow: everything here is falsifiable by construction — every claim ships with a runnable reproduction and a negative control, so you can prove me wrong before you trust me. If you care about verifier-side failure semantics, agent governance, or how evidence survives context handoffs, this is the workshop.
Work submitted to ITU-T FG-TIDA (Trustworthy Identification for Autonomous Agents), written in an independent-expert capacity:
silent-failure-catalog→ submitted as a verifier-side challenge reference inFG-TIDA/use-casesPR #23: 15 named silent-failure patterns on the catalog's main branch (the v0.1.3 release carries 14) — validation that passes while nothing is checked — each with a runnable reproduction, a fix, and a negative control. Zenodo-archived (concept record 23051637, resolves to the latest version); canonical release tag per the repo's citation note.- Theme #7 — verifier-side requirements and failure semantics: discussion contributions on what a relying party may verify offline, and how verdicts stay re-verifiable without making every party a verifier. The catalog is also referenced in theme #6 (intent-based security policies).
FG-TIDA/wg1-ra-aaiPR #2 — reference-architecture chapter 4: offline re-verifiability of agent attestation results, aligned with RFC 9334 (RATS) role separation.- Merged:
FG-TIDA/use-casesPR #18 — completing the submissions index.
| Layer | Repos | One line |
|---|---|---|
| Theory | lgd-theory · xlgd · xcgs-manifesto | Machine-checkable lifecycle model: registry · evidence · gates. |
| Protocol | uibc-core · uibc-competition · silent-failure-catalog · assayance | Executable evidence/registry/validator core, the UIBC-MEM benchmark, and the verifier-side silent-failure challenge reference. |
| Applications | agent-skills · agent-memory-service · lgd-hub | Agent skill packs, memory service, unified entry hub. The MedXpert medical-device product line runs as a separate, parallel line — see the plain-language pointer below. |
One umbrella, used consistently: LGD — Lifecycle Governance Doctrine — LGD (theory), UIBC (executable protocol), MedXpert (medical-device compliance applications — parallel to, not inside, the umbrella); XLGD remains the X-distinction mark for LGD.
名称状态 (name status) : "SynomosAI" / "MedXpert" — 未申请实体注册、未申请商标注册 (not a registered legal entity; no trademark registered)
graph LR
A[silent-failure-catalog<br/>verifier-side challenge ref] -->|negative controls| B[FG-TIDA #6 / #7<br/>verifier-side failure semantics]
C[uibc-core<br/>evidence + registry] --> D[LGD lifecycle model]
A -->|C7 checks-in-path| E[AVS 0.3 candidates]
- 🔍 New to the idea? Start with silent-failure-catalog — read one mode, run its repro, kill it with the fix.
- 🛠 Building agent systems? uibc-core gives you registry / evidence / gates you can wire into your own lifecycle (Apache-2.0).
- 🏛 Tracking FG-TIDA? Watch this account — FG-TIDA submissions and follow-ups land here first.
- 🌐 Prefer plain language? medxpert.cn — the medical-device compliance line, in prose.
Work here is run with a registry, receipts and a permission matrix — registered, evidenced, gated.
- ⭐ Star or 👀 watch a repo if a mode / primitive saves you a bug — it tells me what to deepen next.
- 🐛 Found a claim that doesn't reproduce? That is the best issue to open. Negative controls are the house style.
- 💬 Ask me about verifier-side validation, agent evidence, or medical-device compliance tooling.
- ➕ Follow for standards-track work (ITU-T FG-TIDA), new silent-failure modes, and machine-checkable governance primitives.
- Email: zhaoxinghua09@gmail.com
- ORCID: 0009-0001-0512-1237
- Site: https://zhaoxinghua09-cell.github.io/lgd-hub/
- LinkedIn: https://www.linkedin.com/in/steven-zhao-9156a197
- X (Twitter): @zhaoxing4100
© 2026 赵兴华 / Steven Zhao (ORCID 0009-0001-0512-1237). All rights reserved. 理论署名 (attribution) : LGD(Lifecycle Governance Doctrine / 全程治理论)— SynomosAI initiative 名称状态 (name status) : "SynomosAI" / "MedXpert" — 未申请实体注册、未申请商标注册 (not a registered legal entity; no trademark registered) 生产参考部署 (production reference, self-reported) : MedXpert ← 非认证、非背书、非监管认可(not a certification or endorsement) 贡献者 (contributors) : LGD 理论组(ResearchGroup)— 理论起草与评审集体署名
All account text, methodology, theory terms, specifications and examples are All Rights Reserved. Code is released under the license stated in each repository (MIT / Apache-2.0 / AGPL-3.0). AI assistance: drafted with AI assistance from sources I read myself; the reading and the position are mine.
Maintained by the rights holder. Public information only; not legal, regulatory, or registration advice.
本账号聚焦于可机器核验的验证方构件——让校验在失效时可见,而不是静默通过。核心理念:每一句声称都自带可运行复现与反向对照,先证伪、后采信。
以独立专家身份向 ITU-T FG-TIDA(可自治智能体可信识别焦点组) 提交的工作:
- silent-failure-catalog —— main 分支上 15 种"静默失败"命名模式的目录(v0.1.3 发布版收录 14 种),每条含可运行复现、修法、反向对照。已作为验证方挑战参考实现提交(
FG-TIDA/use-casesPR #23);Zenodo 归档(概念记录 23051637,解析到最新版本),规范引用 tag 以仓内引用注记为准。 - 主题 #7 验证方失败语义 的讨论贡献(依赖方可离线核验什么、判决如何保持可复验而不把每个人都变成验证者);catalog 亦被 主题 #6(意图安全策略)引用;
wg1-ra-aaiPR #2 参考架构第 4 章:离线可复验性(对齐 RFC 9334 角色分离)。 - 已合并:
use-casesPR #18(补全投稿索引)。
理论层(lgd-theory · xlgd · xcgs-manifesto)→ 协议层(uibc-core · uibc-competition · silent-failure-catalog · assayance)→ 应用层(agent-skills · agent-memory-service · lgd-hub)。MedXpert 医疗器械产品线为并行线,不在伞内。
| 术语 | 层 | 含义 |
|---|---|---|
| LGD(Lifecycle Governance Doctrine / 全程治理论) | 伞 | 对外总称;XLGD 为 LGD 的区别符标识,标明来源 |
| LGD | 理论 | 全生命周期模型:凡自治之物,有籍·有证·有门禁 |
| UIBC | 协议 | 可执行协议:registry / evidence / gates 参考实现 + 基准 |
| MedXpert | 应用 | 医疗器械合规产品线——与 XLGD 伞并行,不在伞内 |
本账号的工作按有籍 · 有证 · 有门禁运行:有注册表、有回执、有权限矩阵。
- 觉得某个模式帮你避了坑 → 给仓点 ⭐/👀,这决定我深挖哪条线。
- 发现哪句声称复现不了 → 开 issue,这是本仓最欢迎的贡献(反向对照是本仓家风)。
- ➕ 关注本账号:ITU-T FG-TIDA 标准线动态、新增静默失败模式、可机器核验的治理构件都会先落在这里。
- 邮箱:zhaoxinghua09@gmail.com | ORCID:0009-0001-0512-1237 | 官网:https://zhaoxinghua09-cell.github.io/lgd-hub/
- LinkedIn:https://www.linkedin.com/in/steven-zhao-9156a197 | X:@zhaoxing4100
© 2026 赵兴华 / Steven Zhao (ORCID 0009-0001-0512-1237). All rights reserved. 理论署名 (attribution) : LGD(Lifecycle Governance Doctrine / 全程治理论)— SynomosAI initiative 名称状态 (name status) : "SynomosAI" / "MedXpert" — 未申请实体注册、未申请商标注册 贡献者 (contributors) : LGD 理论组(ResearchGroup)— 理论起草与评审集体署名
本账号文本、方法论、理论术语、规范与示例保留所有权利;代码依各仓许可证(MIT / Apache-2.0 / AGPL-3.0)使用。AI 辅助声明:理论阅读与立场由本人负责。


